EA
ICPT

Emerald Acquisition’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Emerald Acquisition’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$676K Sell
4,109
-99
-2% -$15.6K ﹤0.01% 2317
2016
Q2 		$605K Buy
+4,208
New +$614K ﹤0.01% 2394

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Emerald Acquisition's ICPT Position: Q3 2016 in Review

Emerald Acquisition reduced its Intercept Pharmaceuticals, Inc. (ICPT) stake by 2.4% in Q3 2016, selling an estimated $15.6K and leaving 4,109 shares worth $676K. The position accounts for ﹤0.01% of the portfolio, ranked #2317.

Emerald Acquisition first reported a position in ICPT in Q2 2016 and has held it in 2 quarters since. 172 funds tracked by Wall St. Rank hold ICPT as of Q3 2016.

  • Emerald Acquisition held 4,109 shares of Intercept Pharmaceuticals, Inc. worth $676K as of Q3 2016.
  • Emerald Acquisition sold 99 Intercept Pharmaceuticals, Inc. shares in Q3 2016, an estimated $15.6K.
  • Intercept Pharmaceuticals, Inc. made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2317 holding.
  • Emerald Acquisition first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2016 and has held it in 2 quarters since.
  • 172 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.